CVS Health Corporation (CVS) fundamentals from SEC filings — revenue $402.1B, net margin 0.4%, diluted EPS $1.39 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $292.1B | $322.5B | $357.8B | $372.8B | $402.1B |
| Net income | $8.0B | $4.3B | $8.3B | $4.6B | $1.8B |
| Net margin | 2.7% | 1.3% | 2.3% | 1.2% | 0.4% |
| Diluted EPS | $6.02 | $3.26 | $6.47 | $3.66 | $1.39 |
| Free cash flow | $15.7B | $13.4B | $10.4B | $6.3B | $7.8B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home